These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8994836)

  • 1. Selection for beta 2-microglobulin mutation in mismatch repair-defective colorectal carcinomas.
    Bicknell DC; Kaklamanis L; Hampson R; Bodmer WF; Karran P
    Curr Biol; 1996 Dec; 6(12):1695-7. PubMed ID: 8994836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MUTYH-associated polyposis carcinomas frequently lose HLA class I expression - a common event amongst DNA-repair-deficient colorectal cancers.
    de Miranda NF; Nielsen M; Pereira D; van Puijenbroek M; Vasen HF; Hes FJ; van Wezel T; Morreau H
    J Pathol; 2009 Sep; 219(1):69-76. PubMed ID: 19462419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectra of spontaneous mutations at the hprt locus in colorectal carcinoma cell lines defective in mismatch repair.
    Ohzeki S; Tachibana A; Tatsumi K; Kato T
    Carcinogenesis; 1997 Jun; 18(6):1127-33. PubMed ID: 9214593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsatellite instability analysis in tumors with different mechanisms for total loss of HLA expression.
    Jimenez P; Cantón J; Concha A; Cabrera T; Fernández M; Real LM; García A; Serrano A; Garrido F; Ruiz-Cabello F
    Cancer Immunol Immunother; 2000 Mar; 48(12):684-90. PubMed ID: 10752476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenic peptides generated by frameshift mutations in DNA mismatch repair-deficient cancer cells.
    Schwitalle Y; Linnebacher M; Ripberger E; Gebert J; von Knebel Doeberitz M
    Cancer Immun; 2004 Nov; 4():14. PubMed ID: 15563124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA mismatch binding defects, DNA damage tolerance, and mutator phenotypes in human colorectal carcinoma cell lines.
    Branch P; Hampson R; Karran P
    Cancer Res; 1995 Jun; 55(11):2304-9. PubMed ID: 7757980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frameshift somatic mutations in gastrointestinal cancer of the microsatellite mutator phenotype.
    Yamamoto H; Sawai H; Perucho M
    Cancer Res; 1997 Oct; 57(19):4420-6. PubMed ID: 9331106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frameshift peptide-derived T-cell epitopes: a source of novel tumor-specific antigens.
    Linnebacher M; Gebert J; Rudy W; Woerner S; Yuan YP; Bork P; von Knebel Doeberitz M
    Int J Cancer; 2001 Jul; 93(1):6-11. PubMed ID: 11391614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Confirmation that somatic mutations of beta-2 microglobulin correlate with a lack of recurrence in a subset of stage II mismatch repair deficient colorectal cancers from the QUASAR trial.
    Barrow P; Richman SD; Wallace AJ; Handley K; Hutchins GGA; Kerr D; Magill L; Evans DG; Gray R; Quirke P; Hill J
    Histopathology; 2019 Aug; 75(2):236-246. PubMed ID: 31062389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta2-microglobulin mutations in microsatellite unstable colorectal tumors.
    Kloor M; Michel S; Buckowitz B; Rüschoff J; Büttner R; Holinski-Feder E; Dippold W; Wagner R; Tariverdian M; Benner A; Schwitalle Y; Kuchenbuch B; von Knebel Doeberitz M
    Int J Cancer; 2007 Jul; 121(2):454-8. PubMed ID: 17373663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation in the beta 2m gene is not a frequent event in head and neck squamous cell carcinomas.
    Feenstra M; Rozemuller E; Duran K; Stuy I; van den Tweel J; Slootweg P; de Weger R; Tilanus M
    Hum Immunol; 1999 Aug; 60(8):697-706. PubMed ID: 10439315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of mutator phenotype in familial colorectal cancer patients not fulfilling amsterdam criteria.
    Kim JC; Lee KH; Ka IH; Koo KH; Roh SA; Kim HC; Yu CS; Kim TW; Chang HM; Gong GY; Kim JS
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6159-68. PubMed ID: 15448003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsatellite instability in the mitochondrial DNA of colorectal carcinomas: evidence for mismatch repair systems in mitochondrial genome.
    Habano W; Nakamura S; Sugai T
    Oncogene; 1998 Oct; 17(15):1931-7. PubMed ID: 9788436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic mutations of the coding microsatellites within the beta-2-microglobulin gene in mismatch repair-deficient colorectal cancers and adenomas.
    Clendenning M; Huang A; Jayasekara H; Lorans M; Preston S; O'Callaghan N; Pope BJ; Macrae FA; Winship IM; Milne RL; Giles GG; English DR; Hopper JL; Win AK; Jenkins MA; Southey MC; Rosty C; Buchanan DD;
    Fam Cancer; 2018 Jan; 17(1):91-100. PubMed ID: 28616688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creating CTL targets with epitope-linked beta 2-microglobulin constructs.
    Uger RA; Barber BH
    J Immunol; 1998 Feb; 160(4):1598-605. PubMed ID: 9469415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 8-Hydroxyguanosine repair is defective in some microsatellite stable colorectal cancer cells.
    Parker AR; O'Meally RN; Oliver DH; Hua L; Nelson WG; DeWeese TL; Eshleman JR
    Cancer Res; 2002 Dec; 62(24):7230-3. PubMed ID: 12499263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability.
    Liu B; Nicolaides NC; Markowitz S; Willson JK; Parsons RE; Jen J; Papadopolous N; Peltomäki P; de la Chapelle A; Hamilton SR
    Nat Genet; 1995 Jan; 9(1):48-55. PubMed ID: 7704024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA Class I Analysis Provides Insight Into the Genetic and Epigenetic Background of Immune Evasion in Colorectal Cancer With High Microsatellite Instability.
    Kawazu M; Ueno T; Saeki K; Sax N; Togashi Y; Kanaseki T; Chida K; Kishigami F; Sato K; Kojima S; Otsuka M; Kawazoe A; Nishinakamura H; Yuka M; Yamamoto Y; Yamashita K; Inoue S; Tanegashima T; Matsubara D; Tane K; Tanaka Y; Iinuma H; Hashiguchi Y; Hazama S; Khor SS; Tokunaga K; Tsuboi M; Niki T; Eto M; Shitara K; Torigoe T; Ishihara S; Aburatani H; Haeno H; Nishikawa H; Mano H
    Gastroenterology; 2022 Mar; 162(3):799-812. PubMed ID: 34687740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Routine testing for mismatch repair deficiency in sporadic colorectal cancer is justified.
    Ward RL; Turner J; Williams R; Pekarsky B; Packham D; Velickovic M; Meagher A; O'Connor T; Hawkins NJ
    J Pathol; 2005 Dec; 207(4):377-84. PubMed ID: 16175654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of inactivation of mismatch repair genes in human colorectal cancer cell lines: the predominant role of hMLH1.
    Wheeler JM; Beck NE; Kim HC; Tomlinson IP; Mortensen NJ; Bodmer WF
    Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10296-301. PubMed ID: 10468602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.